4.5 Article

N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 7, 期 6, 页码 618-622

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00056

关键词

Isoquinoline/quinoline sulfonamides; 5-HT6 receptor antagonist; Alzheimer's disease; cognitive decline; novel object recognition task; forced swim test; Vogel test

资金

  1. project Prokog [UDA-POIG.01.03.01-12-063/09-00]
  2. European Union from the European Fund of Regional Development (EFRD)
  3. Polish Ministry of Science and Higher Education (MNiSW) [NN405 671540]
  4. Institute of Pharmacology, Polish Academy of Sciences

向作者/读者索取更多资源

A series of N1-azinylsulfonyl-3-(1,2,3,6,tetrahyrdopyridin-4-yl)-1H-indole derivatives was designed to obtain highly potent 5-HT6 receptor ligands. The study allowed for the identification of 25 (4-{[5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-1-yl]sulfonyl}isoquinoline), a potent and selective 5-HT6 receptor antagonist. The selected compound, was evaluated in vivo in a novel object recognition (NOR) and forced swim (FST) tests in rats, demonstrating distinct pro-cognitive and antidepressant-like properties (MED = 1 mg/kg and 0.1 mg/kg, i.p., respectively). Compound SB-742457, used as comparator, reversed memory deficits in NOR task in similar doses, while in FST it was active in 10-30-fold higher dose (3 mg/kg). In contrast to SB-742457, which was active in Vogel test (MED = 3 mg/kg), compound 25 displayed no anxiolytic activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats

Natalia Malikowska-Racia, Joanna Golebiowska, Agnieszka Nikiforuk, Shaun Yon-Seng Khoo, Piotr Popik

Summary: The antidepressant effects of (S)-ketamine have revolutionized depression treatment, but it also produces psychotomimetic effects. A recent study found that (S)-ketamine leads to time underestimation, while (R)-ketamine does not affect timing. The study evaluated the antidepressant effects and timing-related actions of (R)- and (S)-ketamine, as well as fluoxetine, in male rats. The results showed that (S)-ketamine and fluoxetine had similar antidepressant effects, while (R)-ketamine only affected reinforcement rate and peak location without impacting timing.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Cocaine-Induced Time-Dependent Alterations in Cytochrome P450 and Liver Function

Joanna Jastrzebska, Wladyslawa Anna Daniel

Summary: Cytochrome P450 is involved in the metabolism of drugs, substances of abuse, and endogenous substrates. Cocaine affects the dopaminergic system and may also alter the regulation of cytochrome P450 during the addiction process. The effects of cocaine on liver cytochrome P450 enzymes depend on various factors and can lead to hepatotoxicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Isomeric Activity Cliffs-A Case Study for Fluorine Substitution of Aminergic G Protein-Coupled Receptor Ligands

Wojciech Pietrus, Rafal Kurczab, Dawid Warszycki, Andrzej J. J. Bojarski, Jurgen Bajorath

Summary: In this study, a total of 898 F-containing isomeric analog sets were identified and analyzed for structure-activity relationship (SAR) in the ChEMBL database. The results showed significant differences in affinity for some isomeric compounds against different aminergic GPCRs, and the change of fluorine position could lead to a significant change in potency. Additionally, a computational workflow was proposed to score the fluorine positions in the molecule.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

1-(Arylsulfonyl-isoindol-2-yl)piperazines as 5-HT6R Antagonists: Mechanochemical Synthesis, In Vitro Pharmacological Properties and Glioprotective Activity

Vittorio Canale, Wojciech Trybala, Severine Chaumont-Dubel, Paulina Koczurkiewicz-Adamczyk, Grzegorz Satala, Ophelie Bento, Klaudia Blicharz-Futera, Xavier Bantreil, Elzbieta Pekala, Andrzej J. Bojarski, Frederic Lamaty, Philippe Marin, Pawel Zajdel

Summary: In addition to the canonical Gs adenylyl cyclase pathway, the serotonin type 6 receptor (5-HT6R) recruits additional signaling pathways that control cognitive function, brain development, and synaptic plasticity in an agonist-dependent and independent manner. The development of biased ligands with different functional profiles at specific 5-HT6R-elicited signaling pathways may provide a novel therapeutic perspective in neurodegenerative and psychiatric diseases. A newly synthesized compound 3g exhibits neutral antagonist activity at the 5-HT6R-operated Gs signaling and inverse agonist activity at the Cdk5 pathway, making it a promising biased ligand to investigate the role of these signaling pathways in neurodegenerative diseases.

BIOMOLECULES (2023)

Article Chemistry, Medicinal

Selective 5-HT6 Receptor Ligands (Agonist and Antagonist) Show Different Effects on Antipsychotic Drug-Induced Metabolic Dysfunctions in Rats

Anna Partyka, Katarzyna Gorecka, Joanna Gdula-Argasinska, Natalia Wilczynska-Zawal, Magdalena Jastrzebska-Wiesek, Anna Wesolowska

Summary: Patients taking antipsychotic drugs have a higher likelihood of developing metabolic syndrome, characterized by abdominal obesity, elevated glucose levels, and dyslipidemia. Current treatments for the metabolic side effects of antipsychotic drugs are not satisfactory. Ligands of the serotonin 6 receptor may offer a promising supplement to antipsychotic therapy. This study examined the effects of different antipsychotic drugs alone and in combination with a selective 5-HT6 agonist or antagonist on weight gain, food intake, lipid profile, glucose level, and adipose and gastrointestinal hormones in rats.

PHARMACEUTICALS (2023)

Article Chemistry, Medicinal

Design and synthesis of novel arylurea derivatives of aryloxy (1-phenylpropyl) alicyclic diamines with antimicrobial activity against multidrug-resistant Gram-positive bacteria

Vittorio Canale, Joanna Czekajewska, Karolina Klesiewicz, Monika Papiez, Agata Kuziak, Karolina Witek, Kamil Piska, Dagmara Niemiec, Patryk Kasza, Elzbieta Pekala, Joanna Empel, Magdalena Tomczak, Elzbieta Karczewska, Pawel Zajdel

Summary: The increasing resistance of bacteria to antibiotics necessitates the development of new effective antimicrobial agents. Through screening, compound 44 was identified to have promising antibacterial activity against drug-resistant Gram-positive bacteria, including MRSA and VREfm. However, it showed no activity against Gram-negative bacteria.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Design, Synthesis and Biological Evaluation of Quinoline-8-Sulfonamides as Inhibitors of the Tumor Cell-Specific M2 Isoform of Pyruvate Kinase: Preliminary Study

Krzysztof Marciniec, Zuzanna Rzepka, Elwira Chrobak, Stanislaw Boryczka, Malgorzata Latocha, Dorota Wrzesniok, Artur Beberok

Summary: Cancer cells regulate their metabolism for growth and division. PKM2, a key glycolytic enzyme, is involved in cancer metabolism and is considered a target for cancer treatment. In this study, new compounds were designed and synthesized to modulate PKM2 activity. Compound 9a was found to effectively reduce pyruvate levels in lung cancer cells and exhibit selective cytotoxicity. These findings suggest a potential for developing novel analogs for cancer treatment.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats

Nazarine Mokhtar, Marcin Drop, Florian Jacquot, Sylvain Lamoine, Eric Chapuy, Laetitia Prival, Youssef Aissouni, Vittorio Canale, Frederic Lamaty, Pawel Zajdel, Philippe Marin, Stephane Doly, Christine Courteix

Summary: Diabetic neuropathy can cause chronic pain and associated cognitive deficits. This study found that 5-HT6 receptor inverse agonists and rapamycin can alleviate mechanical hyperalgesia and cognitive deficits in a rat model of diabetic neuropathic pain. The 5-HT6 receptor ligands also showed efficacy in reducing tactile allodynia in other types of neuropathic pain. In addition, disrupting the interaction between 5-HT6 receptors and mTOR can alleviate both painful and cognitive symptoms in diabetic rats. Targeting the constitutive activity of 5-HT6 receptors or the 5-HT6 receptor-mTOR interaction could be valuable strategies for treating diabetic neuropathic pain and cognitive co-morbidities.

BIOMOLECULES (2023)

Article Chemistry, Medicinal

Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats

Katarzyna Grychowska, Uriel Lopez-Sanchez, Mathieu Vitalis, Geoffrey Canet, Grzegorz Satala, Agnieszka Olejarz-Maciej, Joanna Golebiowska, Rafal Kurczab, Wojciech Pietrus, Monika Kubacka, Christophe Moreau, Maria Walczak, Klaudia Blicharz-Futera, Xavier Bantreil, Gilles Subra, Andrzej J. Bojarski, Frederic Lamaty, Carine Becamel, Charleine Zussy, Severine Chaumont-Dubel, Piotr Popik, Hugues Nury, Philippe Marin, Laurent Givalois, Pawel Zajdel

Summary: The multifactorial origin and neurochemistry of Alzheimer's disease (AD) call for the development of multitarget treatment strategies. This study reports a first-in-class triple acting compound that targets serotonin type 6 and 3 receptors (5-HT-Rs) and monoamine oxidase type B (MAO-B) as an approach for treating AD.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Clinical Neurology

Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats

Natalia Malikowska-Racia, Maciej Koniewski, Joanna Golebiowska, Piotr Popik

Summary: This study examined the immediate and sustained antidepressant-like effects of psilocybin and LSD in rats. The results showed that psilocybin had an acute effect, but neither drug demonstrated long-term antidepressant-like effects.

JOURNAL OF PSYCHOPHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats

Anna Haduch, Ewa Bromek, Wojciech Kuban, Agnieszka Basinska-Ziobron, Przemyslaw Danek, Natalia Alenina, Michael Bader, Wladyslawa Daniel

Summary: The depletion of brain serotonin in aging rats results in decreased mRNA and protein levels of key liver drug-metabolizing CYP enzymes, but increased enzyme activities. This suggests that brain serotonin has a regulatory role in liver CYP function, affecting drug metabolism in mature and senescent animals differently.

PHARMACOLOGICAL REPORTS (2023)

Article Pharmacology & Pharmacy

Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands

Katarzyna Szczepanska, Andrzej J. J. Bojarski, Piotr Popik, Natalia Malikowska-Racia

Summary: This study evaluated the pharmacological profile of selected sigma-1 receptor (s(1)R) ligands using a novel object recognition (NOR) test, indicating differences in cognitive functions between s(1)R agonists and antagonists.

PHARMACOLOGICAL REPORTS (2023)

Article Chemistry, Multidisciplinary

Multistep Mechanochemical Synthesis of PZ-1190, a Multitarget Antipsychotic Agent

Vittorio Canale, Michal Kaminski, Wojciech Trybala, Michal Abram, Krzysztof Marciniec, Xavier Bantreil, Frederic Lamaty, Jan Rodriguez Parkitna, Pawel Zajdel

Summary: A solid-state approach was used to synthesize compound PZ-1190, a multitarget ligand for serotonin and dopamine receptors with potential antipsychotic activity. The developed multistep mechanochemical protocol improved the overall yield, reduced the reaction time, and decreased the use of toxic reagents and organic solvents. The described procedures represent rare examples of mechanochemical reduction and aliphatic alcohol oxidation, which could be sustainable methods for obtaining crucial compounds.

ACS SUSTAINABLE CHEMISTRY & ENGINEERING (2023)

暂无数据